Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Thrive Earlier Detection

Biotech & Life Sciences · Cambridge, United States · Founded 2019 Unicorn

Developing CancerSEEK, a blood-based test for early-stage cancer detection

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

16 investors on Thrive Earlier Detection's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
Exact Sciences
Casdin Capital
Cowin Venture
BlueCross BlueShield Venture Partners
Third Rock Ventures
Section 32
Series B+ 10 investors entered at this stage
Lux Capital
Intermountain Ventures
Bain Capital Life Sciences
Janus Henderson Investors
Perceptive Advisors
Moore Strategic Ventures
Rock Springs Capital
Sands Capital Management
Driehaus Capital Management
Brown Advisory

Global footprint

Where Thrive Earlier Detection has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Patent intelligence

$240k patent portfolio · 1 active families

Estimated portfolio value
$240k
0.01% of valuation · 1180× smaller than top peer Verily ($283M)
1 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Thrive Earlier Detection

An AI-synthesized read of the highest-engagement posts about Thrive Earlier Detection on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Thrive Earlier Detection on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.